• 1
    Johnson EH, Windsor JJ, Clark CG. Emerging from obscurity: biological, clinical and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev 2004; 17: 553570.
  • 2
    Girginkardesler N, Coskun S, Balcioglu IC, Ertan P, Ok UZ. Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole. Clin Microbiol Infect 2003; 9: 110113.
  • 3
    Ayadi A, Bahri I. Dientamoeba fragilis: pathogenic flagellate? Bull Soc Pathol Exot 1999; 92: 299301.
  • 4
    Butler WP. Dientamoeba fragilis. An unusual intestinal pathogen. Dig Dis Sci 1996; 41: 18111813.
  • 5
    Crotti D, D’Annibale ML, Fonzo G et al. Dientamoeba fragilis is more prevalent than Giardia duodenalis in children and adults attending a day care centre in Central Italy. Parasite 2005; 12: 165170.
  • 6
    Grendon JH, Digiacomo RF, Frost FJ. Descriptive features of Dientamoeba fragilis infections. J Trop Med Hyg 1995; 98: 309315.
  • 7
    Stark D, Beebe N, Marriott D et al. Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population. J Clin Microbiol 2005; 43: 27182723.
  • 8
    Windsor JJ, Rafay AM, Srenoy AK, Johnson EH. The incidence of Dientamoeba fragilis in faecal samples submitted for routine microbiological analysis. Br J Biomed Sci 1998; 55: 172175.
  • 9
    Stark DJ, Beebe N, Marriott D et al. Dientamoebiasis: clinical importance and recent advances. Trends Parasitol 2006; 22: 9296.
  • 10
    Lagace-Wiens PR, VanCaeseele PG, Koschik C. Dientamoeba fragilis: an emerging role in intestinal disease. Can Med Assoc J 2006; 175: 468469.
  • 11
    Cuffari C, Oligny L, Seidman EG. Dientamoeba fragilis masquerading as allergic colitis. J Pediatr Gastroenterol Nutr 1998; 26: 1620.
  • 12
    Spencer MJ, Chapin MR, Garcia LS. Dientamoeba fragilis: a gastrointestinal protozoan infection in adults. Am J Gastroenterol 1982; 77: 565569.
  • 13
    Kean BH, Malloch CL. The neglected ameba: Dientamoeba fragilis. A report of 100 ‘pure’ infections. Am J Dig Dis 1966; 11: 735746.
  • 14
    Preiss U, Ockert G, Broemme S et al. On the clinical importance of D. fragilis infections in childhood. J Hyg Epidemiol Microbiol Immunol 1991; 35: 2734.
  • 15
    Keystone JS, Proctor E, Glenn C et al. Safety and efficacy of diphetarsone in the treatment of amoebiasis, non pathogenic amoebiasis and trichuriasis. Trans R Soc Trop Med Hyg 1983; 77: 8486.
  • 16
    Vandenberg O, Souayah H, Mouchet F et al. Treatment of Dientamoeba fragilis infection with paromomycin. Pediatr Infect Dis J 2007; 26: 8890.
  • 17
    Chan FT, Guan MX, Mackenzie AM et al. Susceptibility testing of Dientamoeba fragilis ATCC  30948 with iodoquinol, paromomycin, tetracycline, and metronidazole. Antimicrob Agents Chemother 1994; 38: 11571160.
  • 18
    Lamp KC, Freeman CD, Klutman NE et al. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet 1999; 36: 353373.
  • 19
    Garcia LS, Bruckner DA. Macroscopic and microscopic examination of fecal specimens. In: GarciaLS, BrucknerDA, eds, Diagnostic medical parasitology, 2nd edn. Washington, DC: American Society for Microbiology, 1993; 501535.
  • 20
    Pearson RD. Agents active against parasites and Pneumocystis carinii. In: MandellGL, BennettJE, DolinR, eds, Basic principles in the diagnosis and management of infectious diseases, 5th edn. New York: Churchill Livingstone, 2000; 505539.
  • 21
    Norberg A, Nord CE, Evengard B. Dientamoeba fragilis—a protozoal infection which may cause severe bowel distress. Clin Microbiol Infect 2003; 9: 6568.
  • 22
    Ito R, Sakagami J, Kataoka K et al. Chronic diarrhea and protein-losing gastroenteropathy caused by Dientamoeba fragilis. J Gastroenterol 2004; 39: 11171119.